BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 28481898)

  • 21. Rational Design of Zika Virus Subunit Vaccine with Enhanced Efficacy.
    Tai W; Chen J; Zhao G; Geng Q; He L; Chen Y; Zhou Y; Li F; Du L
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31189716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A single-dose plasmid-launched live-attenuated Zika vaccine induces protective immunity.
    Zou J; Xie X; Luo H; Shan C; Muruato AE; Weaver SC; Wang T; Shi PY
    EBioMedicine; 2018 Oct; 36():92-102. PubMed ID: 30201444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dengue and Zika Virus Domain III-Flagellin Fusion and Glycan-Masking E Antigen for Prime-Boost Immunization.
    Lin HH; Yang SP; Tsai MJ; Lin GC; Wu HC; Wu SC
    Theranostics; 2019; 9(16):4811-4826. PubMed ID: 31367259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zika virus structural biology and progress in vaccine development.
    Lin HH; Yip BS; Huang LM; Wu SC
    Biotechnol Adv; 2018; 36(1):47-53. PubMed ID: 28916391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunization With a Novel Human Type 5 Adenovirus-Vectored Vaccine Expressing the Premembrane and Envelope Proteins of Zika Virus Provides Consistent and Sterilizing Protection in Multiple Immunocompetent and Immunocompromised Animal Models.
    Guo Q; Chan JF; Poon VK; Wu S; Chan CC; Hou L; Yip CC; Ren C; Cai JP; Zhao M; Zhang AJ; Song X; Chan KH; Wang B; Kok KH; Wen Y; Yuen KY; Chen W
    J Infect Dis; 2018 Jul; 218(3):365-377. PubMed ID: 29617816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Measles Virus-Based Vaccine Candidate Mediates Protection against Zika Virus in an Allogeneic Mouse Pregnancy Model.
    Nürnberger C; Bodmer BS; Fiedler AH; Gabriel G; Mühlebach MD
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vesicular Stomatitis Virus and DNA Vaccines Expressing Zika Virus Nonstructural Protein 1 Induce Substantial but Not Sterilizing Protection against Zika Virus Infection.
    Li A; Xue M; Attia Z; Yu J; Lu M; Shan C; Liang X; Gao TZ; Shi PY; Peeples ME; Boyaka PN; Liu SL; Li J
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32554698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Recombinant Subunit Based Zika Virus Vaccine Is Efficacious in Non-human Primates.
    Medina LO; To A; Lieberman MM; Wong TAS; Namekar M; Nakano E; Andersen H; Yalley-Ogunro J; Greenhouse J; Higgs S; Huang YS; Vanlandingham DL; Horton JS; Clements DE; Lehrer AT
    Front Immunol; 2018; 9():2464. PubMed ID: 30467501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant Zika virus envelope protein elicited protective immunity against Zika virus in immunocompetent mice.
    Liang H; Yang R; Liu Z; Li M; Liu H; Jin X
    PLoS One; 2018; 13(3):e0194860. PubMed ID: 29590178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Live vaccine infection burden elicits adaptive humoral and cellular immunity required to prevent Zika virus infection.
    Yau C; Gan ES; Kwek SS; Tan HC; Ong EZ; Hamis NZ; Rivino L; Chan KR; Watanabe S; Vasudevan SG; Ooi EE
    EBioMedicine; 2020 Nov; 61():103028. PubMed ID: 33045466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Vaccine Based on a Modified Vaccinia Virus Ankara Vector Expressing Zika Virus Structural Proteins Controls Zika Virus Replication in Mice.
    Pérez P; Q Marín M; Lázaro-Frías A; Jiménez de Oya N; Blázquez AB; Escribano-Romero E; S Sorzano CÓ; Ortego J; Saiz JC; Esteban M; Martín-Acebes MA; García-Arriaza J
    Sci Rep; 2018 Nov; 8(1):17385. PubMed ID: 30478418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chimeric yellow fever 17D-Zika virus (ChimeriVax-Zika) as a live-attenuated Zika virus vaccine.
    Giel-Moloney M; Goncalvez AP; Catalan J; Lecouturier V; Girerd-Chambaz Y; Diaz F; Maldonado-Arocho F; Gomila RC; Bernard MC; Oomen R; Delagrave S; Burdin N; Kleanthous H; Jackson N; Heinrichs J; Pugachev KV
    Sci Rep; 2018 Sep; 8(1):13206. PubMed ID: 30181550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The combined vaccination protocol of DNA/MVA expressing Zika virus structural proteins as efficient inducer of T and B cell immune responses.
    Pérez P; Martín-Acebes MA; Poderoso T; Lázaro-Frías A; Saiz JC; Sorzano CÓS; Esteban M; García-Arriaza J
    Emerg Microbes Infect; 2021 Dec; 10(1):1441-1456. PubMed ID: 34213405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Highly Expressing, Soluble, and Stable Plant-Made IgG Fusion Vaccine Strategy Enhances Antigen Immunogenicity in Mice Without Adjuvant.
    Diamos AG; Pardhe MD; Sun H; Hunter JGL; Kilbourne J; Chen Q; Mason HS
    Front Immunol; 2020; 11():576012. PubMed ID: 33343565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles.
    Lin YL; Yu CI; Hu YC; Tsai TJ; Kuo YC; Chi WK; Lin AN; Chiang BL
    Vaccine; 2012 Feb; 30(7):1305-12. PubMed ID: 22214888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine.
    Tebas P; Roberts CC; Muthumani K; Reuschel EL; Kudchodkar SB; Zaidi FI; White S; Khan AS; Racine T; Choi H; Boyer J; Park YK; Trottier S; Remigio C; Krieger D; Spruill SE; Bagarazzi M; Kobinger GP; Weiner DB; Maslow JN
    N Engl J Med; 2021 Sep; 385(12):e35. PubMed ID: 34525286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of Dosing Regimen and Adjuvant Type on the Immunogenicity of Novel Recombinant Zika Virus-Like Particles.
    Brzuska G; Szewczyk B; Krol E
    Microbiol Spectr; 2023 Feb; 11(1):e0288522. PubMed ID: 36541807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An inactivated recombinant rabies virus displaying the Zika virus prM-E induces protective immunity against both pathogens.
    Jin H; Jiao C; Cao Z; Huang P; Chi H; Bai Y; Liu D; Wang J; Feng N; Li N; Zhao Y; Wang T; Gao Y; Yang S; Xia X; Wang H
    PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009484. PubMed ID: 34086672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A purified inactivated vaccine derived from Vero cell-adapted zika virus elicits protection in mice.
    Oh HS; Yoon JW; Lee S; Kim SO; Hong SP
    Virology; 2021 Aug; 560():124-130. PubMed ID: 34087565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maternal immunization with a DNA vaccine candidate elicits specific passive protection against post-natal Zika virus infection in immunocompetent BALB/c mice.
    Wang R; Liao X; Fan D; Wang L; Song J; Feng K; Li M; Wang P; Chen H; An J
    Vaccine; 2018 Jun; 36(24):3522-3532. PubMed ID: 29753607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.